demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 mild to moderate
COVID-19 mild to moderate
anti-inflammatory therapies
clarithromycine Rashad ...
colchicine COL-COVID ...
non-steroidal anti-inflammatory drugs
Indomethacin Ravichandran

1 studies excluded by filtering options 0

9250 Guzman-Esquivel, 2022 000selection pending